PRNewswire/ -- miraDry, the leader in in-office sweat and odor reduction, is thrilled to announce its recognition as a winner ...

Prescriptions for a range of common 'over the counter' remedies are no longer available on the NHS after a crackdown in ...

Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

Specialists rely on the hyperhidrosis severity scale to assess the seriousness of the situation, as well as the discomfort in order to find an appropriate treatment. Treatments to consider The first ...

Complete enrollment in its DMT310 Phase 3 STAR-1 clinical trial in moderate-to-severe acne. Dermata expects to complete enrollment in the STAR-1 study by the end of 2024 and plans to announce topline ...

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

Heat stroke is primarily classified into exertional and non-exertional forms. Exertional heat stroke results from strenuous ...

Botanix Pharmaceuticals Limited (AU:BOT) has released an update. Botanix Pharmaceuticals Limited is set to make waves in the dermatology market ...

Botox is one of the significant advances in dealing with hyperhidrosis: a practical, noninvasive, and long-term solution to a situation that, properly allowed to develop, can adversely affect ...

These are known as disease-modifying treatments. One of these, lecanemab, has been licensed for private use. Other medications are under review to see if they could be prescribed to people in the very ...

To commemorate Hyperhidrosis Awareness Month, miraDry is engaging its providers worldwide to pledge to educate and advocate for patients around the world. The company is hosting a global virtual event ...

According to analysis by Future Market Insights (FMI), the global axillary hyperhidrosis treatment market was valued at USD 1.6 billion in 2022 and is expected to reach approximately USD 3.3 billion ...